|
|
 |
POLICY/ETHICS
Environmental Implications of Engineered Nanomaterials
Volume 1, Issue 1
View Abstract
Next Steps for the National Nanotechnology Initiative
Volume 1, Issue 1
View Abstract
Nanotechnology Legislation in the 108th Congress
Volume 1, Issue 1
View Abstract
Reviewing the NNP: Focus on Commercialization
Volume 1, Issue 2
View Abstract
Standards In Nanotechnology
Volume 1, Issue 2
View Abstract
Environmental Regulation of Nanotechnology: Avoiding Big Mistakes For Small Machines
Volume 1, Issue 3
View Abstract
Societal and Ethical Interactions with Nanotechnology (“SEIN”) – An Introduction
Volume 1, Issue 4
View Abstract
Nano Hyperbole and Lessons from Earlier Technologies
Volume 1, Issue 4
View Abstract
Nanotechnology and the International Regime on Chemical and Biological Weapons
Volume 2, Issue 1
View Abstract
Export Control Pitfalls for Government-Academic Partnerships in Nanotechnology
Volume 2, Issue 1
View Abstract
Nanotech Meets the FDA: A Success Story about the First Nanoparticulate Drugs Approved by the FDA
Volume 2, Issue 2
View Abstract
Angstrom Medica: Securing FDA Approval and Commercializing a Nanomedical Device
Volume 2, Issue 2
View Abstract
Nanotechnology and the “Valley of Death”
Volume 2, Issue 3
View Abstract
Nanotechnology Standards: A Foundation for Innovation
Volume 2, Issue 3
View Abstract
Media Portraits of Nanotech in North American Written Media
Volume 2, Issue 4
View Abstract
Nanotechnology: Getting It Right the First Time
Volume 3, Issue 1
View Abstract
Preparing for Future Health Litigation: The Application of Products Liability Law to Nanotechnology
Volume 3, Issue 1
View Abstract
The NELSI Imperative: Nano Ethical, Legal and Social Issues,
and Federal Policy Development
Volume 3, Issue 2
View Abstract
Reflecting Upon the UK’s Citizens’ Jury on Nanotechnologies: NanoJury UK
Volume 3, Issue 2
View Abstract
Nanotechnology and the FDA: What Are the Scientific and Regulatory
Considerations for Products Containing Nanomaterials?
Volume 3, Issue 3
View Abstract
Nanomaterial Consumer Products and FDA Regulation:
Regulatory Challenges and Necessary Amendments
Volume 3, Issue 3
View Abstract
Assessing the Need for Nanotechnology Education Reform in the United States
Volume 3, Issue 4
View Abstract
Regulating Nanoscience: A Proposal and a Response to J. Clarence Davies
Volume 3, Issue 4
View Abstract
The Product Life Cycle and Challenges to Nanotechnology Regulation
Volume 3, Issue 4
View Abstract
TSCA and Engineered Nanoscale Substances
Volume 4, Issue 1
View Abstract
Integrating Ethical Considerations into Funding Decisions for Emerging Nanotechnologies
Volume 4, Issue 1
View Abstract
Nano-Based Drugs and Medical Devices: FDA's Track Record
Volume 4, Issue 2
View Abstract
Nanoassemblers: A Likely Threat?
Volume 4, Issue 2
View Abstract
The Impact of Systems Biology on the Pharmacogenomics Revolution
Volume 4, Issue 3
View Abstract
The Challenges of Adopting Voluntary Health, Safety and Environment Measures for Manufactured Nanomaterials: Lessons From the Past For More Effective Adoption in the Future
Volume 4, Issue 3
View Abstract
Everything New Is Old Again: Patentable Novelty of Nanoscale Chemical Materials Does Not Imply Newness Under the TSCA and the FDCA
Volume 4, Issue 4
View Abstract
Good Governance: Evolution of the Nanoscale Materials Stewardship Program
Volume 4, Issue 4
View Abstract
Dual-Use Export Controls on Nanotechnology
Volume 5, Issue 1
View Abstract
FDA Labeling of Cosmetics Containing Nanoscale Materials
Volume 5, Issue 1
View Abstract
Nanotechnology and the Attribution of Responsibility
Volume 5, Issue 2
View Abstract
Nanotechnology Safety: A Framework for Identifying and Complying with Workplace Safety Requirements
Volume 5, Issue 2
View Abstract
Mediating the Uncertainty and Abstraction of Nanotechnology Promotion and Control: “Late” Lessons from Other “Early Warnings” in History
Volume 5, Issue 3
View Abstract
The Implications of Recent Nanomaterials Toxicity Studies for the Nanotech Community
Volume 5, Issue 3
View Abstract
A Nano-Mesothelioma False Alarm
Volume 5, Issue 3
View Abstract
Auditing as a Tool for Ensuring Compliance with Nanotechnology Safety Requirements
Volume 5, Issue 4
View Abstract
Listen Up! The Need for Public Engagement in Nanoscale Science and Technology
Volume 5, Issue 4
View Abstract
The GoodNanoGuide: A Novel Approach for Developing Good Practices for Handling Engineered Nanomaterials in an Occupational Setting
Volume 6, Issue 1
View Abstract
Nanomedicine: Issues of Privacy and Informed Consent
Volume 6, Issue 1
View Abstract
Evaluating a Nanomaterial Operation’s Compliance with Environmental Requirements: Selected Environmental Audit Statutes and Policies
Volume 6, Issue 2
View Abstract
Nano Risk Governance: Current Developments and Future Perspectives
Volume 6, Issue 2
View Abstract
Nanobiotechnology Regulation: A Proposal for Self-Regulation with Limited Oversight
Volume 6, Issue 2
View Abstract
Demands for Regulation of NanoSilver – The First Battle for the Industry’s Future?
Volume 6, Issue 3
View Abstract
Examples of Recent EPA Regulation of Nanoscale Materials Under the Toxic Substances Control Act
Volume 6, Issue 3
View Abstract
Regulation of Nanoparticles: Trying to Keep Pace with a Scientific Revolution
Volume 6, Issue 4
View Abstract
Emerging Safety Issues at University Nanomaterials Labs: Calling Officer Buckle and Gloria
Volume 6, Issue 4
View Abstract
U.S. Export Controls: Implications for Developing Nanotechnology Business in China
Volume 6, Issue 4
View Abstract
Risk Management and Nanotechnology: Insurance Concerns About Small Particles
Volume 7, Issue 1
View Abstract
Nanotechnology Demands a New Relationship Between Federal, State, and Local Regulatory Agencies
Volume 7, Issue 2
View Abstract
Project on Emerging Nanotechnologies – Consumer Product Inventory Evaluated
Volume 7, Issue 2
View Abstract
An Industry-Driven Approach to EHS Issues: “The NanoSafety Consortium for Carbon”
Volume 7, Issue 3
View Abstract
Nanotechnology and Exploding Steamboats: “Nobody to Blame”
Volume 7, Issue 3
View Abstract
State and Local Regulation of Nanotechnology: Two Opposing Methodologies
Volume 7, Issue 3
View Abstract
Nanofoods: European and U.S. Regulatory Approaches
Volume 7, Issue 4
View Abstract
Nanotechnology: Risk Assessment and Risk Management Perspective
Volume 8, Issue 1
View Abstract
Accelerating Innovation: The Nanotechnology Institute
Volume 8, Issue 3
View Abstract
FDA’s Regulation of Nanotechnology: Will the New Draft Guidance Help Industry?
Volume 8, Issue 3
View Abstract
Navigating FDA’s Approach to Approval of Nanoparticle-Based Drugs and Devices
Volume 8, Issue 4
View Abstract
A Critical Study on the Cooperative Research and Development Agreements of U.S. Federal Laboratories: Technology Commercialization and the Public Interest
Volume 9, Issue 1
View Abstract
Use of Nanoscale Materials in Commercial Sunscreen Products
Volume 9, Issue 1
View Abstract
FDA Issues Draft Guidance on Use of Nanotechnology in Food and Food Packaging
Volume 9, Issue 2
View Abstract
Nano-Torts on the Horizon: A Jack and Jill Story
Volume 9, Issue 2
View Abstract
Recent Developments in Nanotechnology Standards
Volume 10, Issue 2
View Abstract
Brief Overview of Current Developments in Nanotechnology EHS Regulation in the U.S.
Volume 11, Issue 1
View Abstract
The Regulatory and Liability Implications of Nanoscale Drug Delivery in the Human Body
Volume 11, Issue 1
View Abstract
CNTs, Nano-TiO2, and Nanosilver: Assessing Risk and Investing in Safety
Volume 11, Issue 2
View Abstract
EPA Targets Nanotechnology: Hi-Ho, Nanosilver, Away?
Volume 11, Issue 3
View Abstract
EPA Issues Stop Sales Order for Unregistered Food Containers Containing Nanosilver: What Are the Implications?
Volume 11, Issue 3
View Abstract
Graphene: Regulatory Considerations for the “Wonder Material”
Volume 11, Issue 3
View Abstract
FDA’s Final and Draft Nanotechnology Guidance Documents: No Big Surprises
Volume 12, Issue 1
View Abstract
|
|
